Tag - shinya-yamanaka

 
 

SHINYA YAMANAKA

Japan Times
BUSINESS
Jun 24, 2020
Fast Retailing chief to donate ¥10 billion for medical research
Fast Retailing Co. Chairman and CEO Tadashi Yanai said Wednesday he will donate ¥10 billion ($94 million) to Kyoto University to support its medical research under two Nobel Prize winners, Tasuku Honjo and Shinya Yamanaka.
Japan Times
JAPAN / Science & Health
Apr 18, 2019
Patients doing well after landmark 2017 retina transplants via donor iPS cells in Japan
Of the five, four have maintained their level of visual acuity after the operations, while one experienced an improvement in their vision.
Japan Times
JAPAN
Jun 14, 2018
Osaka makes final pitch to host 2025 World Expo
Osaka made its final pitch Wednesday in Paris to host the 2025 World Expo, emphasizing the Kansai region's history as a center of Nobel-prize winning scientific research and telling expo delegates that the central government is willing to spend ¥24 billion to ensure 100 countries are able to participate in the event.
Japan Times
JAPAN / Science & Health
Jan 25, 2018
Nobel winner Shinya Yamanaka to donate salary after iPS research scandal at Kyoto University
Nobel laureate Shinya Yamanaka, who heads a research institute for induced pluripotent stem cells at Kyoto University, is considering donating his salary to the facility to take responsibility for data fabrication in a paper by one of its researchers, sources have said.
Japan Times
JAPAN / Science & Health
Jan 23, 2018
Unstable work seen as a factor as Kyoto University admits iPS researcher falsified data in paper
Experts say unstable employment conditions faced by scientists are behind the string of research-related scandals in the nation.
Japan Times
JAPAN / Media / BIG IN JAPAN
Nov 11, 2017
On the quest for the holy grail for as long as we live
Is death inevitable? True, everyone born before Aug. 4, 1900, has proved mortal (the world's oldest-known living person, a Japanese woman named Nabi Tajima, was born on that date). But the past is only an imperfect guide to the future, as the effervescent present is ceaselessly teaching us.
Japan Times
JAPAN / Science & Health
Aug 7, 2017
World's first method for mass-producing platelets from iPS cells unveiled by Kyoto startup
A Kyoto startup unveils a way to mass-produce platelets, a key component in clotting, that could reduce doctors' dependency on donated blood to minimize bleeding.
JAPAN / Science & Health
Aug 17, 2016
Kyoto University team produces quality stem cells from umbilical blood
A research institute produces stem cells for stockpiled use in regenerative medicine from the umbilical blood of a newborn.
Japan Times
JAPAN / Science & Health
Jul 28, 2016
Japanese Nobel laureate Yamanaka seeks to use AI in iPS cell treatment
Japanese Nobel Prize winner Shinya Yamanaka says he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem (iPS) cells in regenerative medicine.
Japan Times
BUSINESS / Companies / FOCUS
Jun 16, 2015
Nobel laureate Yamanaka allies with Takeda in hunt for blockbuster drugs
When Christophe Weber went after his first deal as head of Takeda Pharmaceutical Co., he veered off the well-worn path to the U.S. and Europe and went to Japan's Kyoto University instead.
JAPAN / Science & Health
Apr 17, 2015
Kyoto University and Takeda join hands on iPS cell venture
Kyoto University's iPS cell research institute and Takeda Pharmaceutical Co. said Friday they will launch a 10-year, ¥20 billion joint program to focus on regenerative medicine and drug discovery using iPS cells.
EDITORIALS
Sep 21, 2014
iPS treatment window opens
This month's transplant of a retina sheet made of induced pluripotent stem cells into a human being marks a Japanese milestone toward the application of iPS cells in the treatment of disease.
Japan Times
JAPAN / Science & Health / NATURAL SELECTIONS
Feb 15, 2014
Stem-cell leap defied Japanese norms
It's not surprising that last week Haruko Obokata issued a plea for privacy. On Jan. 29 she published a scientific paper on stem cells that could revolutionize medicine, and overnight the researcher based at the Riken Center for Developmental Biology (CDB) in Kobe became a domestic and international star.
Japan Times
JAPAN / Science & Health
Feb 11, 2014
Yamanaka takes issue with claims STAP cells are safer than iPS option
Nobel Prize-winning scientist Shinya Yamanaka, facing reporters in Kyoto, decried "three misconceptions" about the induced pluripotent stem, or iPS, cells that he developed in relation to STAP cells were recently unveiled.
Japan Times
JAPAN
Dec 5, 2013
Center starts iPS cell stockpiling project
The Kyoto University Center for iPS Cell Research and Application has started creating induced pluripotent stem cells (iPS cells) for stockpiling for future use in regenerative medicine and clinical research, officials said.
JAPAN / Science & Health
Jul 31, 2013
World's first iPS clinical research for retina regeneration begins
The world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina begins Thursday, according to a Japanese team of researchers.
EDITORIALS
Jul 8, 2013
Safety first with iPS transplants
A Kyoto University research team is to be applauded for getting the go-ahead to test the safety of an iPS transplant procedure on six patients with an age-related eye disease.
EDITORIALS
Mar 27, 2013
Making clinical use of iPS cells
Japan's Institute of Physical and Chemical Research asks the health ministry for permission to do a clinical study using iPS cells to treat eye disease.
Japan Times
JAPAN / Science & Health
Feb 22, 2013
New prize awards Yamanaka $3 million
A U.S. foundation sponsored by top U.S. business executives said Wednesday it has selected 11 researchers, including Japanese stem cell researcher and Nobel laureate Shinya Yamanaka, as inaugural winners of the newly launched Breakthrough Prize in Life Sciences for their past achievements in the field of life sciences.
JAPAN / Science & Health
Jan 30, 2013
Stockpile of artificial stem cells in works
Kyoto University professor Shinya Yamanaka has revealed that a project to stockpile artificially derived stem cells for clinical research will start in early February.

Longform

Later this month, author Shogo Imamura will open Honmaru, a bookstore that allows other businesses to rent its shelves. It's part of a wave of ideas Japanese booksellers are trying to compete with online spaces.
The story isn't over for Japan's bookstores